ID: ALA4103790

Max Phase: Preclinical

Molecular Formula: C17H18N4O5

Molecular Weight: 358.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C1=C(C)NC(=O)N(CCC#N)C1c1cccc([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C17H18N4O5/c1-3-26-16(22)14-11(2)19-17(23)20(9-5-8-18)15(14)12-6-4-7-13(10-12)21(24)25/h4,6-7,10,15H,3,5,9H2,1-2H3,(H,19,23)

Standard InChI Key:  UJZWRUVZABWVRL-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated T-type calcium channel alpha-1H subunit 1913 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Voltage-gated L-type calcium channel alpha-1C subunit 1321 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.35Molecular Weight (Monoisotopic): 358.1277AlogP: 2.41#Rotatable Bonds: 6
Polar Surface Area: 125.57Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.68CX Basic pKa: CX LogP: 1.18CX LogD: 1.18
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -1.47

References

1. Teleb M, Zhang FX, Farghaly AM, Aboul Wafa OM, Fronczek FR, Zamponi GW, Fahmy H..  (2017)  Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.,  134  [PMID:28399450] [10.1016/j.ejmech.2017.03.080]

Source